Radial artery or saphenous vein for coronary artery bypass grafting

Area of Science:

• Cardiology
• Vascular Surgery
• Grafting Techniques

Background:

• Coronary artery disease (CAD) is a leading global cardiovascular condition, impacting millions.
• Coronary artery bypass grafting (CABG) is a primary treatment for severe CAD.
• The saphenous vein (SV) has been the traditional graft, but newer evidence favors the radial artery (RA).

Purpose of the Study:

• To review and synthesize current literature comparing radial artery (RA) and saphenous vein (SV) graft efficacy in coronary artery bypass grafting (CABG).
• To evaluate the impact of RA versus SV on cardiac outcomes and patient survival in multivessel CAD.

Main Methods:

• Systematic literature review of studies comparing RA and SV grafts in CABG patients.
• Analysis of data focusing on graft patency, cardiac events, and long-term survival.
• Synthesis of findings from recent clinical studies and meta-analyses.

Main Results:

• Emerging data indicate superior long-term cardiac outcomes and survival rates with radial artery (RA) grafts compared to saphenous vein (SV) grafts.
• Radial artery grafts demonstrate better patency and reduced risk of adverse cardiac events in specific patient populations.
• Saphenous vein grafts, while historically standard, show comparatively lower long-term efficacy in recent comparative studies.

Conclusions:

• The radial artery (RA) presents a promising alternative to the saphenous vein (SV) for coronary artery bypass grafting (CABG), particularly for patients with multivessel coronary artery disease (CAD).
• Evidence suggests RA grafts are associated with improved patient survival and cardiac outcomes, warranting consideration in surgical planning.
• Further research should continue to elucidate the long-term benefits and optimal patient selection for RA utilization in CABG.